Page 7 - Pharmaceutical Firms

Aurobindo terminates $900-million Sandoz product acquistion deal

A mutual decision to cancel the agreement was taken as approval from US Federal Trade Commission was not obtained within anticipated timelines

Clinical trial norms may be eased for developing coronavirus vaccine

Sources said no fresh approvals would be given for clinical trials, except for those related to Covid-19.

Big Pharma's addiction to profit

Book review of PHARMA: Greed, Lies, and the Poisoning of America

The post-COVID-19 world

Policymakers and pharma companies will have to work together to speed up trials of new vaccines and legislate to ensure essential drugs and tests are affordable and available

Coronavirus impact: Govt keeps close tabs on drug supply, pricing

Govt keeping tabs on raw material stock, prices, and helping firms airlift APIs

Laudable move by Pharmexcil

The Pharmexcil came up with clarifications for its members and representations to the government highlighting some difficulties

Coronavirus: Govt to consider airlifting APIs only if industry pays

Due to Coronavirus outbreak in China, supply of pharmaceutical goods and components are being delayed

Coronavirus impact: Centre restricts exports of 13 APIs, formulations

Exports of 13 APIs - including paracetamol, tinidazole, metronidazole, vitamin B1, vitamin B6, vitamin B12, acyclovir, progesterone - along with formulations mmade from these APIs, would be restricted

US pharma firms speed up work on coronavirus vaccine: Donald Trump

"We're talking about a vaccine. They are moving along very quickly. All pharmaceutical companies are moving along very quickly," Trump said

Dr Reddy's gets 1 observation from USFDA after inspecting Hyderabad plant

Earlier, the drug major had said that the US health regulator has issued a Form 483 with two observations after inspecting the facility but later it was issued revised Form 483 with one observation

Coronavirus a game-changer, can't rely on China for drug supply: French FM

And the resulting industrial slowdown in China would have a "direct impact" on industrial resupply, he said

Firms in pharma supply chain develop system to track counterfeit drugs

Medicines identified as counterfeit may be contaminated, contain the wrong ingredient, or have no active ingredient at all

Budget 2020: Jan Aushadhi growth could hurt branded pharma market

In the 2020-21 Union Budget, finance minister Nirmala Sitharaman proposed to expand the scheme to all districts, and offer 2,000 medicines and 300 surgicals by 2024

Govt plans single-window assistance mechanism for pharma investors by March

On the sidelines of an annual event of the Indian Drug Manufacturers' Association, a senior government official said plans had been readied in this regard

Online pharmacies see record funding in 2019, investments double to $321 mn

The industry experts are expecting more activity in the segment, especially if a delayed regulatory framework takes place during the current year.

Uptick in domestic segment, biz growth continue to drive Ipca Laboratories

Further rerating of stock will hinge on USFDA resolution

Legacy pharma brands spin gold for GSK, Pfizer; keep newcomers off the turf

Repositioning an old brand helps expand the footprint, say analysts

Novartis, Merck, Allergan raise US prices, 445 drugs to cost more in 2020

That is above the average of 404 drug price increases in the first three days of January over the past five years

Biocon and Equillium Inc. expand license agreement for itolizumab

The companies have expanded their collaboration and license agreement

SME Tracker: Bulk-drug firms' prospects boosted by focus on niche molecules

Strong demand for formulations and increasing health insurance penetration would also support growth